Fullerenes in biomedicine (pages 391 to 404)

A. Djordjevi (Faculty of Science, Department of Chemistry, University of Novi Sad, Serbia), G. Bogdanovi, S. Dobri

Publication in peer-reviewed medical journals (pages 405 to 410)

R. Igi (Department of Anesthesiology and Pain Management, John H. Stroger Hospital of Cook County, Chicago, USA)

Ten years of the Journal of the Balkan Union of Oncology – a brief account (pages 411 to 413)

Lj. Vukovi Deki (Institute for Oncology and Radiology of Serbia, Beograd, Serbia), D. Rapaji, A. E. Athanassiou

AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening (pages 415 to 418)

R. Doherty (AIDIT Project Manager, The Institute of Cancer Research, London, United Kingdom), J. Lubinski, E. Manguoglu, G. Luleci, M. Christie, P. Craven, E. Bancroft, A. Mitra, S. Morgan, R. Eeles

Second line chemotherapy with methotrexate and gemcitabine in patients with relapsing head and neck cancer (pages 419 to 424)

E. Xydakis (Department of Medical Oncology, Agii Anargiri Cancer Hospital, Kiffisia, Athens, Greece), E. Repassos, M. Poulou, M. Papadakou, C. Boukis, G. Panagos

Compliance with adjuvant chemotherapy in non-small cell lung cancer. The experience of a single institution evaluating a cohort of 356 patients (pages 425 to 432)

M. Dediu (Medical Oncology Department, Institute of Oncology Bucharest, Bucharest, Romania), A. Alexandru, D. Median, R. Anghel, A. Tarlea, P. Iorga, M. Movanu

Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors – Bulgarian experience (pages 433 to 438)

B. Abramova (Specialized Hospital for Pediatric Oncohematology and Bone Marrow Transplantation, Sofia, Bulgaria), M. Jordanova, G. Michailov, D. Konstantinov, I. Christosova, Dr. Bobev

Clinical aspects of gynecological cancers’ prophylaxis (pages 439 to 445)

V. Zlatkov (Clinic of Gynecology, National Transport Hospital “King Boris III”, Sofia, Bulgaria), P. Kostova

Combination of interventional pulmonology techniques (Nd:YAG laser resection and brachytherapy) with external beam radiotherapy in the treatment of lung cancer patients with Karnofsky Index 50 (pages 447 to 456)

V. anak (Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Clinic for Pulmonary Oncology, Department for Interventional Pulmonology, Serbia), B. Zari, A. Milovanev, S. Jovanovi, E. Budiin, T. arev, N. Lali, V. Nievi, G. Balaban

Expandable wallstents for treatment of tracheoesophageal fistuals of malignant origin (pages 457 to 462)

N. Baltayiannis (Department of Thoracic Surgery, Metaxa Cancer Hospital, Piraeus, Greece), D. Magoulas, N. Bolanos, D. Anagnostopoulos, A. Kaya, Ch. Kontogiannopoulos, S. Nicolouzos, E. Georgiannakis, K. Kastrinaki, E. Kayiani, A. Chatzimichalis

Talc pleurodesis: Comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions (pages 463 to 467)

A. Debeljak (University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia), P. Kecelj, N. Triller, S. Letonja, I. Kern, L. Debevec, A. Rozman

Synergistic interaction between a mixed ligand copper (II) chelate complex and two anticancer agents in T47D human breast cancer cells in vitro (pages 469 to 476)

G. D. Geromichalos (Laboratory of Cell Culture – Molecular Modeling and Drug Design, Symeonidio Research Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece), D. T. Trafalis, G. A. Katsoulos, A. Papageorgiou, P. Dalezis, E. B. Triandafillidis, C. C. Hadjikostas, A. Athanassiou

Chromosomal aberrations level in peripheral blood lymphocytes of women with polycystic ovary syndrome (pages 477 to 480)

A. Nersesyan (National Center of Oncology, Yerevan, Republic of Armenia), A. Martirosyan, G. Parsadanyan, G. Zalinyan

Plasminogen activator inhibitor -1 gene 4G5G polymorphism in patients with breast cancer (pages 481 to 484)

A. Eroglu (Department of General Surgery and Surgical Oncology, Numune State Hospital, Konya, Turkey), A. Ulu, R. Cam, N. Akar

Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases (pages 485 to 489)

A. Chloraki Bobota (Departments of Immunology, Metaxa Cancer Hospital, Piraeus, Greece), C. Megalakaki, P. Repousis, Ir. Chalkiopoulou, I. Lalaki, D. T. Trafalis, A. E. Athanassiou, Chr. Mitsouli Mentzikof

Is there a role of whole body bone scan in early stages of non small cell lung cancer patients (pages 491 to 497)

L. Iordanidou (Department of Nuclear Medicine, Metaxa Cancer Hospital, Piraeus, Greece), E. Trivizaki, S. Saranti, A. Georgakopoulos, N. Bolanos, N. Baltagiannis, P. Koutsiouba

Bone scintigraphy in the monitoring of treatment effect of bisphosphonates in bone metastatic breast cancer (pages 499 to 504)

L. Chavdarova (Clinic of Nuclear Medicine, National Hospital of Oncology, Sofia, Bulgaria), E. Piperkova, A. Tsonevska, K. Timcheva, M. Dimitrova

99mTc-MIBI myocardial perfusion scintigraphy for assessment of myocardial damage after radiotherapy in patients with breast cancer (pages 505 to 509)

A. Tzonevska (Department of Nuclear Medicine, National Oncological Hospital, Sofia, Bulgaria), K. Tzvetkov, V. Parvanova, M. Dimitrova

Nuclear medicine approaches in the monitoring of thyroid cancer patients (pages 511 to 518)

S. Sergieva (Sofia Cancer Centre, Bulgaria), T. Hadjieva, M. Doldurova, S. Stefanova, A. Dudov

Primitive neurectodermal tumors A case of extraosseous Ewing’s sarcoma of the small intestine and review of the literature (pages 519 to 522)

C. Batziou (First Department of Oncology, Errikos Dunant Hospital, Athens, Greece), G. P. Stathopoulos, K. Petraki, C. Papadimitriou, S. K. Rigatos, E. Kondopodis, J. Stathopoulos, S. Batzios

Impact of PETCT on initial staging, restaging and treatment management of anal cancer A clinical case with literature review (pages 523 to 527)

E. Piperkova (Clinic of Nuclear Medicine, National Oncology Center Hospital, Sofia, Bulgaria), B. Raphael, M. Altinay, I. Castellon, R. Libes, N. Sandella, H. Abdel-Dayem

Hodgkin’s disease in the nasopharynx (pages 529 to 531)

B. M. Atasoy (Marmara University Hospital, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey), U. Abaciolu, . ztrk, R. zdemir, T. Tecimer

The outstanding British surgeon Percivall Pott (1714-1789) and the first description of an occupational cancer (pages 533 to 539)

G. Androutsos (Institute of History of Medicine, University Claude Bernard, Lyons, France)